20Mar 2019
THE TREATMENT OF TRAUMATIC BRAIN INJURY IN EXPERIMENTAL ANIMALS BY PYRIMIDINE DERIVATIVES.
- Medical and Pharmaceutical Institute ? A branch of state educational institution of higher professional education ?Volgograd State Medical University?.
- Medical & clinical Biochemistry. LU, Faculty of Public Health.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Traumatic Brain Injury (TBI) is a significant civilian health problem. TBI triggers complex changes on the central nervous system. NSE and GFAP may provide drug target identification. We aim in this study to investigate the possible effects of pyrimidine derivatives in the recovery of TBI.
Materials and methods: Research was conducted on 80 male animal rats, with body weights varying from 200-220g with experimental brain injuries (?weight-drop method?). The concentration of NSE and GFAP and the level of cerebral edema were estimated after the injury in animals that were treated with pyrimidine derivative (50 mg/kg) and choline alfoscerate (50 mg/kg).
Results: The level of biomarkers in group of negative control was elevated. After the treatment the experimental animals with pyrimidine derivative GLY and choline alfoscerate the concentration of NSE and GFAP decreased as well as cerebral edema.
Conclusion: Administration of GLY one hour after injury at a dose 50 mg/kg minimizes cerebral edema and the damage of neurons.
1. Voronkov A.V., Kalashnikova S.A., Khoury E.I. The traumatic brain injury modeling by ?the weight-dropped method?// Современные проблемы науки и образования. ? 2016. ? № 5.;URL: https://www.science-education.ru/ru/article/view?id=25242.
2. 2. Dambinova Svetlana A., Ronald L. Hayes Biomarkers for Traumatic Brain Injury.2012: 3-11.
3. Feala Jacob D., Mohamed Diwan M. AbdulHameed Systems Biology approaches for discovering biomarkers for traumatic brain injury, Journal of Neurotrauma. 2013; 30:1101-1116.
4. Ismet Topcu The effects of lornoxicam on brain edema and blood brain barrier following diffuse traumatic brain injury in rats Turkish Journal of Trauma and Emergency Surgery. 2013; 19(4): 294-298.
5. Jun Ding, Zhengang Ding Proteomic Analysis after Traumatic Brain Injury in Rats: The Research for Potential Biomarkers//Arq Neuropsiquiatr. 2015;73(4):342-349.
6. L.Fletcher, C.C.Rider, and C.B. Taylor Enolase isoenzymes. Chromatographic and immunological characteristics of rat brain enolase. Biochim Biophys Acta.1976; 452:245-252.
7. Pelinka, Linda E.; Hertz Nonspecific increase of systemic NSE after trauma;clinical and experimental findings Basic Science aspects. 2005; 24(2) :119-123.
8. Risdall Jane E., David Menon Traumatic Brain Injury / Philosophical Transactions of Royal Society. 2011; 366: 241-250.
9. Tomaszewski Dariusz Biomarkers of Brain Damage and Postoperative Cognitive. Hindawi Publishing Corporation BioMed Research International.2015. doi:10.1155/2015/402959.
10. X. Anton Alvarez, Jesus Figueroa Peptidergic Drugs for the Treatment of Traumatic Brain Injury// Future Neurology.2013; 8(2):175-192.
11. U.E. Pleins, M.C. Morganty-Kossmann S-100β reflects the extend of injury and outcome, whereas neuronal specific enolase is a better indicator neirounflammation in patients with severe traumatic brain injury. J. Neurotrauma.2001; 18:491-408.
12. Sean Shen, Rachel R. Ogorzalek Loo Addressing the Needs of Traumatic Brain Injury with Clinical Proteomics.2014;11:11.
13. Ovsyannikov D.M. Social and Epidemiological Aspects of Craniocerebral Trauma. 2012;8(3).
[Voronkov A. V, M. M. Khaled, Khoury E. I and Pozdnyakov D. I. (2019); THE TREATMENT OF TRAUMATIC BRAIN INJURY IN EXPERIMENTAL ANIMALS BY PYRIMIDINE DERIVATIVES. Int. J. of Adv. Res. 7 (Mar). 799-803] (ISSN 2320-5407). www.journalijar.com
Khoury Elena
Lebanese University\ Pyatigorsk Medical and Pharmaceutical Institute
Download Full Paper
Download PDF No. of Downloads: 16 | No. of Views: 91
